Veradigm | MDRX - Current Assets


Veradigm reported $810.77M in Current Assets for its fiscal quarter ending in September of 2022.





Current Assets Change Date
Alcidion AUD 23.69M 4.6M Jun/2025
Ambu A/S DKK 3.05B 111M Dec/2025
Amplifon EUR 441.88M 238.03M Sep/2025
Cardinal Health USD 39.23B 693M Dec/2025
Centene USD 40.37B 3.69B Dec/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Cigna USD 47.81B 1.08B Dec/2025
Computer Programs Systems USD 102.57M 12.31M Sep/2025
Convatec Group USD 793.3M 70.6M Dec/2024
CVS Health USD 74.71B 2.4B Dec/2025
Diasorin EUR 759.63M 400.63M Jun/2025
Elevance Health USD 63B 777M Dec/2025
General Electric Aerospace USD 40.6B 522M Dec/2025
Gulf Medical Proj AED 431.22M 73.8M Dec/2025
Humana USD 32.73B 19M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Laboratory Of America USD 4.02B 58.3M Dec/2025
Maximus USD 1.42B 170.28M Dec/2025
McKesson USD 59.7B 190M Dec/2025
Med Life RON 705.54M 18.75M Sep/2025
Molina Healthcare USD 12.44B 108M Dec/2025
Omnicell USD 680.07M 20.45M Dec/2025
Oriola-kd EUR 614M 11.4M Sep/2025
Owens Minor USD 547.87M 1.58B Dec/2025
Quest Diagnostics USD 2.38B 29M Dec/2025
Rede D'or Sao Luiz BRL 58.05B 3.2B Sep/2025
Siemens Healthineers EUR 14.19B 96M Dec/2025
Sonova Holding CHF 1.91B 466.3M Jun/2025
Supermax Corporation Bhd MYR 1.2B 104.95M Sep/2025
UnitedHealth USD 95.07B 1.37B Sep/2025
Veeva Systems USD 8B 885.78M Dec/2025
Veradigm USD 810.77M 18M Sep/2022
Xerox USD 3.75B 210M Sep/2025